Skip to content
OpenCapital
Get started

Proto Labs PRLB Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1

Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 at other companies

Boston Beer logo
Boston BeerSAM
$1.28M-21.5%
TRV
Trevi Therapeutics, Inc.TRVI
$1.13M+87.5%
KEE
Keel Infrastructure Corp. Common StockKEEL
$680.5K-73.6%
HNI logo
HNIHNI
$0—
Healthcare Services Group logo
Healthcare Services GroupHCSG
$325K0.0%
HTF
Heartflow, Inc. Common StockHTFL
$2.15M+330%

Other financials

Income statement

See full
Revenue$139.3M+10.4%
Gross profit$63.6M+14.2%
Operating income$9.8M+117%
Net income$8.1M+125%
EPS (diluted)$0.33+120%

Balance sheet

See full
Cash & equivalents$124.0M+49.9%
Total debt$2.6M-16.6%
Total equity$683.1M+4.0%
Total assets$778.6M+5.6%

Cash flow

See full
Operating cash flow$17.5M-4.6%
CapEx$3.5M+181%
Free cash flow$14.0M-18.2%

Valuation

See full
Market cap$1.9B+59.7%

Profitability

See full
Gross margin44.9%+0.5pp
Operating margin5.6%+1.7pp
Net margin4.7%+1.6pp
FCF margin10.4%-3.1pp

Returns & leverage

See full
Return on equity3.8%+1.6pp
Debt / equity0×0.0×
Current ratio3.5×+0.4×

Where this comes from

Reported directly by Proto Labs in its filing.

Tagged under the XBRL concept us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1.

The official record: Proto Labs’s 10-K, filed February 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about Proto Labs's sharebased compensation arrangement by sharebased payment award options vested in period fair value1.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Proto Labs's sharebased compensation arrangement by sharebased payment award options vested in period fair value1?
Proto Labs (PRLB) reported sharebased compensation arrangement by sharebased payment award options vested in period fair value1 of $575K in Q4 2025.
How has Proto Labs's sharebased compensation arrangement by sharebased payment award options vested in period fair value1 changed year-over-year?
Proto Labs's sharebased compensation arrangement by sharebased payment award options vested in period fair value1 decreased by 0.0% year-over-year, from $575K to $575K.
What is the long-term trend for Proto Labs's sharebased compensation arrangement by sharebased payment award options vested in period fair value1?
Over 4 years (2021 to 2025), Proto Labs's sharebased compensation arrangement by sharebased payment award options vested in period fair value1 has grown at a 2.3% compound annual growth rate (CAGR), from $2.1M to $2.3M.
What does sharebased compensation arrangement by sharebased payment award options vested in period fair value1 mean?
The total fair value of stock options that completed their vesting period during the reporting cycle. This metric reflects the portion of share-based compensation expense that is recognized as employees fulfill their service requirements. It is essential for understanding the ongoing non-cash compensation burden on the company's earnings.